This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Okayama University. Active years: 2016-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2017
Title: Kiyoshi Teshigawara: Innovator in Neutrophil Activation Research
Introduction
Kiyoshi Teshigawara is a prominent inventor based in Okayama, Japan. He has made significant contributions to the field of medical research, particularly in the area of neutrophil activation and its implications for various diseases. With a total of 2 patents, Teshigawara's work focuses on developing therapeutic agents and methods for predicting the severity of systemic inflammatory response syndrome (SIRS).
Latest Patents
Teshigawara's latest patents include innovative approaches to treating diseases caused by neutrophil activation. One of his notable inventions is a neutrophil activation regulator that comprises a histidine-rich glycoprotein (HRG). This invention aims to provide a therapeutic agent for SIRS and other inflammatory diseases. Additionally, he has developed methods for predicting the severity of SIRS by determining the blood level of HRG in affected subjects. His second patent also focuses on a therapeutic agent and inspection method for diseases caused by neutrophil activation, emphasizing the importance of HRG in these conditions.
Career Highlights
Kiyoshi Teshigawara is affiliated with Okayama University, where he conducts his research and development activities. His work has garnered attention for its potential to improve treatment outcomes for patients suffering from inflammatory diseases. Teshigawara's dedication to advancing medical science is evident in his innovative approaches and the practical applications of his inventions.
Collaborations
Throughout his career, Teshigawara has collaborated with esteemed colleagues, including Hidenori Wake and Shuji Mori. These partnerships have contributed to the advancement of research in neutrophil activation and its related therapeutic strategies.
Conclusion
Kiyoshi Teshigawara is a notable inventor whose work in neutrophil activation research has the potential to transform treatment methodologies for inflammatory diseases. His contributions through innovative patents and collaborations highlight the importance of continued research in this critical area of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile